Corrigendum: Current status and future perspectives of liquid biopsy in non-small cell lung cancer

Sunhee Chang; Jae Young Hur; Yoon-La Choi; Chang Hun Lee; Wan Seop Kim

doi:10.4132/jptm.2020.02.27.r

Articles

Page Path: HOME > J Pathol Transl Med > Volume 60(6); 2026 > Article

Correspondence Corrigendum: Current status and future perspectives of liquid biopsy in non-small cell lung cancer: Sunhee Chang¹, Jae Young Hur², Yoon-La Choi³, Chang Hun Lee⁴, Wan Seop Kim²; Journal of Pathology and Translational Medicine 2026;60(6):738-.
DOI: https://doi.org/10.4132/jptm.2020.02.27.r
Published online: November 13, 2026

¹Department of Pathology, Inje University Ilsan Paik Hospital, Goyang, Korea

²Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea

³Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

⁴Department of Pathology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

Corresponding Author: Wan Seop Kim, MD Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea Tel: +82-2-2030-5642, Fax: +82-2-2030-5629, E-mail: wskim@kuh.ac.kr

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

34 Views
1 Download

Full Article

Download PDF

This corrects the article "Current status and future perspectives of liquid biopsy in non-small cell lung cancer" on page 204.

To the Editor,

We found an error in our published article.

Chang S, Hur JY, Choi YL, Lee CH, Kim WS. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. J Pathol Transl Med. 2020; 54(3): 204-212. https://doi.org/10.4132/jptm.2020.02.27.

In the section "FUTURE PERSPECTIVES ON CIRCULATING TUMOR DNA TESTING IN LUNG CANCER," the following sentence was incorrectly stated:

Original:

"However, the overall false-positive rate is 96.4% because of many indeterminate pulmonary nodules."

Corrected:

"However, in the National Lung Screening Trial (NLST), 96.4% of positive low-dose CT screening results were false positives, corresponding to the false discovery rate rather than the conventional false-positive rate."

The original statement incorrectly described the proportion of false-positive results among positive screening results as the overall false-positive rate. The corrected statement clarifies the distinction between these two measures.

We apologize for this error and any confusion it may have caused.

Figure & Data

References

Citations

Citations to this article as recorded by

PubReader
ePub Link

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Corrigendum: Current status and future perspectives of liquid biopsy in non-small cell lung cancer

J Pathol Transl Med. 2026;60(6):738-738. Published online November 13, 2026

DOI: https://doi.org/10.4132/jptm.2020.02.27.r

XML Download

Corrigendum: Current status and future perspectives of liquid biopsy in non-small cell lung cancer